• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于增强稳定性的喷雾干燥胶束、脂质体和固体脂质纳米粒的研发

Development of Spray-Dried Micelles, Liposomes, and Solid Lipid Nanoparticles for Enhanced Stability.

作者信息

Dattani Shradha, Li Xiaoling, Lampa Charina, Barriscale Amanda, Damadzadeh Behzad, Lechuga-Ballesteros David, Jasti Bhaskara R

机构信息

Department of Pharmaceutics and Medicinal Chemistry, University of the Pacific, Stockton, CA 95211, USA.

Inhalation Product Development, PT&D AstraZeneca, LLC, South San Francisco, CA 94080, USA.

出版信息

Pharmaceutics. 2025 Jan 17;17(1):122. doi: 10.3390/pharmaceutics17010122.

DOI:10.3390/pharmaceutics17010122
PMID:39861769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11768165/
Abstract

Micelles, liposomes, and solid lipid nanoparticles (SLNs) are promising drug delivery vehicles; however, poor aqueous stability requires post-processing drying methods for maintaining long-term stability. The objective of this study was to compare the potential of lipid-based micelles, liposomes, and SLNs for producing stable re-dispersible spray-dried powders with trehalose or a combination of trehalose and L-leucine. This study provides novel insights into the implementation of spray drying as a technique to enhance long-term stability for these lipid-based nanocarriers. Aqueous dispersions of LDV-targeted micelles, liposomes, and SLNs loaded with paclitaxel (PTX) were converted into re-dispersible powders using spray drying. The physicochemical properties of the nanocarriers were determined via scanning electron microscopy (SEM), Karl Fischer titration, differential scanning calorimetry (DSC), and dynamic light scattering (DLS). Short-term stability of all nanocarrier formulations was compared by measuring particle size, polydispersity index (PDI), and paclitaxel retention over 7 days at room temperature and at 4 °C. Paclitaxel-loaded micelles, liposomes, and SLN formulations were successfully converted into well-dispersed spray-dried powders with acceptable yields (71.5 to 83.5%), low moisture content (<2%), and high transition temperatures (95.1 to 100.8 °C). SEM images revealed differences in morphology, where nanocarriers spray-dried with trehalose or a combination of trehalose and L-leucine produced smooth or corrugated particle surfaces, respectively. Reconstituted spray-dried nanocarriers maintained their nanosize and paclitaxel content over 7 days at 4 °C. The results of this study demonstrate the potential for the development of spray-dried lipid-based nanocarriers for long-term stability.

摘要

胶束、脂质体和固体脂质纳米粒(SLNs)是很有前景的药物递送载体;然而,较差的水稳定性需要采用后处理干燥方法来维持长期稳定性。本研究的目的是比较基于脂质的胶束、脂质体和SLNs在与海藻糖或海藻糖和L-亮氨酸组合使用时制备稳定的可再分散喷雾干燥粉末的潜力。本研究为将喷雾干燥作为一种增强这些基于脂质的纳米载体长期稳定性的技术的实施提供了新的见解。使用喷雾干燥将负载紫杉醇(PTX)的靶向LDV的胶束、脂质体和SLNs的水分散体转化为可再分散粉末。通过扫描电子显微镜(SEM)、卡尔费休滴定法、差示扫描量热法(DSC)和动态光散射(DLS)测定纳米载体的物理化学性质。通过在室温及4℃下测量7天内的粒径、多分散指数(PDI)和紫杉醇保留率,比较了所有纳米载体制剂的短期稳定性。负载紫杉醇的胶束、脂质体和SLN制剂成功转化为分散良好的喷雾干燥粉末,产率可接受(71.5%至83.5%),水分含量低(<2%),转变温度高(95.1至100.8℃)。SEM图像显示了形态上的差异,其中用海藻糖或海藻糖和L-亮氨酸组合喷雾干燥的纳米载体分别产生了光滑或有波纹的颗粒表面。重构的喷雾干燥纳米载体在4℃下7天内保持其纳米尺寸和紫杉醇含量。本研究结果证明了开发用于长期稳定性的喷雾干燥脂质基纳米载体的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7b7/11768165/5f073af653f5/pharmaceutics-17-00122-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7b7/11768165/36459fc12783/pharmaceutics-17-00122-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7b7/11768165/f62586283fff/pharmaceutics-17-00122-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7b7/11768165/5df3102d65a3/pharmaceutics-17-00122-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7b7/11768165/5ccaf0863884/pharmaceutics-17-00122-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7b7/11768165/5f073af653f5/pharmaceutics-17-00122-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7b7/11768165/36459fc12783/pharmaceutics-17-00122-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7b7/11768165/f62586283fff/pharmaceutics-17-00122-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7b7/11768165/5df3102d65a3/pharmaceutics-17-00122-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7b7/11768165/5ccaf0863884/pharmaceutics-17-00122-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7b7/11768165/5f073af653f5/pharmaceutics-17-00122-g005.jpg

相似文献

1
Development of Spray-Dried Micelles, Liposomes, and Solid Lipid Nanoparticles for Enhanced Stability.用于增强稳定性的喷雾干燥胶束、脂质体和固体脂质纳米粒的研发
Pharmaceutics. 2025 Jan 17;17(1):122. doi: 10.3390/pharmaceutics17010122.
2
Physicochemical characterization and water vapor sorption of organic solution advanced spray-dried inhalable trehalose microparticles and nanoparticles for targeted dry powder pulmonary inhalation delivery.有机溶液推进喷雾干燥可吸入海藻糖微球和纳米粒的物理化学特性及水蒸气吸附作用及其用于靶向干粉肺部递药
AAPS PharmSciTech. 2011 Dec;12(4):1420-30. doi: 10.1208/s12249-011-9704-0. Epub 2011 Oct 25.
3
A comparative study on micelles, liposomes and solid lipid nanoparticles for paclitaxel delivery.用于紫杉醇递送的胶束、脂质体和固体脂质纳米粒的比较研究。
Int J Pharm. 2023 Jan 25;631:122464. doi: 10.1016/j.ijpharm.2022.122464. Epub 2022 Dec 1.
4
Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.含核酸的聚乙烯亚胺纳米粒喷雾干燥粉末的特性研究。
Eur J Pharm Biopharm. 2019 Oct;143:61-69. doi: 10.1016/j.ejpb.2019.08.012. Epub 2019 Aug 21.
5
Effect of cholesterol on the properties of spray-dried lysozyme-loaded liposomal powders.胆固醇对喷雾干燥载脂蛋白脂质体粉末性质的影响。
AAPS PharmSciTech. 2010 Jun;11(2):832-42. doi: 10.1208/s12249-010-9442-8. Epub 2010 May 13.
6
The interplay between trehalose and dextran as spray drying precursors for cationic liposomes.海藻糖与葡聚糖作为阳离子脂质体喷雾干燥前体之间的相互作用。
Int J Pharm. 2024 Mar 5;652:123798. doi: 10.1016/j.ijpharm.2024.123798. Epub 2024 Jan 6.
7
Co-spray dried carbohydrate microparticles: crystallisation delay/inhibition and improved aerosolization characteristics through the incorporation of hydroxypropyl-β-cyclodextrin with amorphous raffinose or trehalose.共喷雾干燥碳水化合物微粒:通过将羟丙基-β-环糊精与无定形棉子糖或海藻糖结合来延迟/抑制结晶并改善雾化特性。
Pharm Res. 2015 Jan;32(1):180-95. doi: 10.1007/s11095-014-1454-8. Epub 2014 Jul 30.
8
Investigation into the effect of varying l-leucine concentration on the product characteristics of spray-dried liposome powders.研究不同浓度 L-亮氨酸对喷雾干燥脂质体粉末产品特性的影响。
J Pharm Pharmacol. 2012 Oct;64(10):1412-24. doi: 10.1111/j.2042-7158.2012.01521.x. Epub 2012 Apr 25.
9
Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.设计、物理化学特性分析和优化有机溶液高级喷雾干燥二棕榈酰磷脂酰胆碱(DPPC)和二棕榈酰磷脂酰乙醇胺聚乙二醇(DPPE-PEG)微米和纳米粒子,用于作为干粉吸入剂气溶胶的靶向呼吸纳米医学递药。
Int J Nanomedicine. 2013;8:275-93. doi: 10.2147/IJN.S30724. Epub 2013 Jan 15.
10
Preparation and Characterization of Spray-Dried Inhalable Powders Containing Polymeric Micelles for Pulmonary Delivery of Paclitaxel in Lung Cancer.喷雾干燥含聚合物胶束的可吸入粉末的制备及特性研究及其用于肺癌中紫杉醇的肺部给药。
J Pharm Pharm Sci. 2018;21(1s):200s-214s. doi: 10.18433/jpps30048.

引用本文的文献

1
Liposomal Encapsulation in Food Systems: A Review of Formulation, Processing, and Applications.食品体系中的脂质体包封:配方、加工及应用综述
Food Sci Nutr. 2025 Aug 4;13(8):e70587. doi: 10.1002/fsn3.70587. eCollection 2025 Aug.
2
Investigation of Nano Spray-Dried, Hyaluronic Acid-Modified Polymeric Micelles for Nasal Administration.用于鼻腔给药的纳米喷雾干燥透明质酸修饰聚合物胶束的研究
Pharmaceutics. 2025 Apr 18;17(4):533. doi: 10.3390/pharmaceutics17040533.
3
Effects of Surface Charge of Inhaled Liposomes on Drug Efficacy and Biocompatibility.

本文引用的文献

1
Spray-dried Solid Lipid Nanoparticles for Enhancing Berberine Bioavailability Oral Administration.喷雾干燥固体脂质纳米粒提高盐酸小檗碱口服生物利用度
Curr Pharm Des. 2023;29(38):3050-3059. doi: 10.2174/0113816128263982231102062745.
2
Influence of Lyophilization and Cryoprotection on the Stability and Morphology of Drug-Loaded Poly(ethylene glycol--ε-caprolactone) Micelles.冻干和冷冻保护对载药聚(乙二醇-ε-己内酯)胶束稳定性和形态的影响
Polymers (Basel). 2023 Apr 21;15(8):1974. doi: 10.3390/polym15081974.
3
Solid Lipid Nanoparticles: Multitasking Nano-Carriers for Cancer Treatment.
吸入性脂质体表面电荷对药物疗效和生物相容性的影响。
Pharmaceutics. 2025 Mar 3;17(3):329. doi: 10.3390/pharmaceutics17030329.
固体脂质纳米粒:用于癌症治疗的多功能纳米载体。
Pharmaceutics. 2023 Mar 3;15(3):831. doi: 10.3390/pharmaceutics15030831.
4
A comparative study on micelles, liposomes and solid lipid nanoparticles for paclitaxel delivery.用于紫杉醇递送的胶束、脂质体和固体脂质纳米粒的比较研究。
Int J Pharm. 2023 Jan 25;631:122464. doi: 10.1016/j.ijpharm.2022.122464. Epub 2022 Dec 1.
5
Mechanism Study on Nanoparticle Negative Surface Charge Modification by Ascorbyl Palmitate and Its Improvement of Tumor Targeting Ability.纳米粒子负表面电荷修饰的机制研究:抗坏血酸棕榈酸酯及其对肿瘤靶向能力的改善。
Molecules. 2022 Jul 9;27(14):4408. doi: 10.3390/molecules27144408.
6
Current approaches of nanomedicines in the market and various stage of clinical translation.市场上纳米药物的当前方法以及临床转化的各个阶段。
Acta Pharm Sin B. 2022 Jul;12(7):3028-3048. doi: 10.1016/j.apsb.2022.02.025. Epub 2022 Mar 1.
7
Stability characterization for pharmaceutical liposome product development with focus on regulatory considerations: An update.药物脂质体产品开发的稳定性特征分析,重点关注监管考虑因素:更新。
Int J Pharm. 2022 Aug 25;624:122022. doi: 10.1016/j.ijpharm.2022.122022. Epub 2022 Jul 15.
8
Development of a Spray-Dried Formulation of Peptide-DNA Nanoparticles into a Dry Powder for Pulmonary Delivery Using Factorial Design.采用析因设计法将肽-DNA 纳米粒喷雾干燥制成干粉用于肺部给药
Pharm Res. 2022 Jun;39(6):1215-1232. doi: 10.1007/s11095-022-03256-4. Epub 2022 Apr 19.
9
A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives.脂质体作为药物传递系统的综述:已批准产品的现状、监管环境和未来展望。
Molecules. 2022 Feb 17;27(4):1372. doi: 10.3390/molecules27041372.
10
Lyophilization of Nanocapsules: Instability Sources, Formulation and Process Parameters.纳米胶囊的冻干:不稳定性来源、配方及工艺参数
Pharmaceutics. 2021 Jul 21;13(8):1112. doi: 10.3390/pharmaceutics13081112.